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Abstract
Background—Patients should understand the risks and benefits of cancer screening in order to
make informed screening decisions.
Objectives—Evaluate the extent of informed decision making in patient-provider discussions for
colorectal (CRC), breast (BrCa), and prostate (PCa) cancer screening.
Design—National random-digit dial telephone survey.
Subjects—English-speaking U.S. adults aged 50 and older who had discussed cancer screening
with a health care provider within the previous two years.
Measurements—Cancer screening survey modules that asked about sociodemographic
characteristics, cancer knowledge, the importance of various sources of information, and self-
reported cancer-screening decision-making processes.
Results—Overall, 1,082 participants completed one or more of the three cancer modules.
Although participants generally considered themselves well informed about screening tests, half or
more could not correctly answer even one open-ended knowledge question for any given module.
Participants consistently overestimated risks for being diagnosed with and dying from each cancer
and overestimated the positive predictive values of PSA tests and mammography. Providers were
the most highly rated information source, usually initiated screening discussions (64–84%), and
often recommended screening (73–90%). However, participants reported providers elicited their
screening preferences in only 31% (CRC women) to 57% (PCa) of discussions. While over 90%
of the discussions addressed the pros of screening, only 19% (BrCa) to 30% (PCa) addressed the
cons of screening.
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Limitations—Recall bias is possible because screening process reports were not independently
validated.
Conclusions—Cancer screening decisions reported by patients who discussed screening with
their health care providers consistently failed to meet criteria for being informed. Given the high
ratings for provider information and frequent recommendations for screening, providers have
important opportunities to ensure that informed decision-making occurs for cancer screening
decisions.
Keywords
prostatic neoplasms; breast neoplasms; colorectal neoplasms; early detection of cancer; decision
making
Introduction
Screening can reduce cancer morbidity and mortality, though relatively few patients who
undergo screening actually achieve this benefit. More commonly, patients face potential
downsides from screening, including false positive tests, psychological distress, additional
testing, overdiagnosis, and treatment complications (1). Given the potential benefits and
harms associated with screening, experts have argued that cancer-screening decisions should
depend on patient preferences and that patients should be provided the opportunity to
participate in an informed decision-making process (2). The elements of this process include
a discussion addressing the patient’s desired role in the decision making, the nature of the
decision, alternative options, uncertainties associated with decision, the patient’s
understanding, and the patient’s preferences (3).
While cancer screening is usually initiated in primary care, the extent to which informed
decision-making occurs in everyday practice has not been well characterized. Much of the
literature addresses only a single cancer, a selected patient population, or provides a limited
description of the screening discussions and decision factors (4–10).
The National Survey of Medical Decisions (DECISIONS) was a nationally representative
telephone survey of English-speaking adults aged 40 and older who recently faced one of
nine common medical decisions, including three types of cancer screening (11).
DECISIONS data provide detailed characterizations of screening discussions and decision-
making from the patient’s perspective. Hoffman and colleagues previously characterized
decision-making processes for men aged 40 and older in the DECISIONS study who faced
prostate cancer screening decisions (12). The purpose of the current analysis was to
characterize discussions of colorectal, breast, and prostate cancer screening between patients
aged 50 and older and their health care providers. We specifically evaluated the variability
in the sources of information that patients relied upon, knowledge, decision processes, and




The DECISIONS study was a list-assisted random-digit-dial telephone survey of a national
probability sample of English-speaking adults aged 40 and older conducted in 2006–7.
Overall, 3,010 subjects completed interviews for a weighted cooperation rate of 86.5% and
weighted response rate of 51.6%. Participants answered a variety of questions about nine
common types of medical decisions, including screening for breast, colorectal, and prostate
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cancer. Complete details of the sampling, response rate, instrument development, and data
collection methodologies are detailed elsewhere (11). All procedures and instruments
received approval from the University of Michigan and Veterans Affairs Ann Arbor Medical
Center institutional review boards.
The survey instrument included an introductory section that assessed decision prevalence,
followed by decision-specific question modules. Participants were deemed eligible to
participate in cancer screening modules if they reported having a screening test within the
preceding two years and/or reported discussing a screening test with their health care
providers. Participants were randomly assigned to complete up to two decision modules
drawn from the set for which they were eligible, with higher probabilities of module
assignment given to the least prevalent decisions.
Within each cancer screening module, participants answered a variety of questions about
their knowledge of basic facts about the particular cancer, the importance of various sources
of information used in making screening decisions, the processes used in making screening
decisions, the communications with their health care providers, and the outcomes of the
decision-making process. The present manuscript focuses on the subset of DECISIONS
participants aged 50 and older who were eligible for breast, colorectal, or prostate cancer
screening modules, were randomly selected to complete one or two of these cancer
screening modules, and who reported discussing cancer screening with a health care
provider before either undergoing testing or electing to not be tested.
We restricted our analyses to participants aged 50 and older to minimize selection bias
because screening for prostate and colorectal cancer in younger age groups has routinely
been recommended for only high-risk individuals (13). Furthermore, breast cancer screening
recommendations for average-risk women aged 40 to 49 are inconsistent (14).
Measures
Participant characteristics—Participants answered standard demographic questions,
including age, gender, race, income, marital status, and education. They also rated their
health status, reported whether they currently had health insurance or a health care provider,
and stated whether they felt that they were at low, average, or high risk for the cancer in
question.
Sources of information—Participants rated, on a 0 to 10 scale (with 0 being “not at all
important” and 10 being “extremely important”), the importance of cancer screening
information obtained from their health care providers, their friends and family, and the
media, respectively, for making their decision about cancer screening. Participants also
indicated whether they (or a designee) had used the Internet to search for information about
the screening decision and, if so, rated the importance of Internet-derived information on the
same 0 to 10 scale.
Cancer-specific knowledge—Each cancer-screening module included 3 to 5 open-
ended knowledge questions (15). All modules asked participants to estimate the lifetime
risks for cancer diagnosis and cancer mortality. We considered responses within a 5
percentage point range that included the actual mortality risk and within a 10 percentage
point range that included the actual incidence risk to be correct. The breast and prostate
cancer screening modules asked about the positive predictive value—the proportions of
patients with positive screening tests that turn out to have cancer, the colorectal cancer
screening module asked about the recommended interval for screening colonoscopy
following a negative examination, and the breast and colorectal cancer screening modules
asked whether there was evidence for the efficacy of screening. The accompanying
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knowledge paper by Fagerlin et al. provides the algorithms used to define the correct
answers and the data sources (15). Participants also rated their perceptions of how well
informed they were about the screening tests using a 0 to 10 scale (with 0 being “not
informed at all” and 10 being “extremely well informed”) (16).
Decision processes and patient-provider communications—The modules asked
participants about the decision-making process for cancer screening, including who raised
the issue of screening, whether the participant had spoken with more than one health care
provider about screening, whether providers elicited the participant’s preference for
screening, and whether the final decision about screening was made by the participant,
provider, or was shared. Modules also asked participants about their communications with
health care providers regarding screening, including the degree to which health care
providers had addressed reasons for or against screening, whether the providers offered
opinions regarding screening and made explicit screening recommendations, and whether
reasons for screening were well explained. The survey also asked participants whether they
underwent testing, their confidence that they made the correct decision about getting or not
getting screened on a 0 to 10 scale (with 0 being “not at all confident” and 10 being
“extremely confident”), and their satisfaction with their level of involvement in the decision-
making process.
Analyses
For each module, we estimated sample means and proportions with 95% confidence
intervals to describe participant characteristics, cancer-specific knowledge, information
sources, and the screening discussion. We used the survey procedures (PROC
SURVEYFREQ and PROC SURVEYMEANS) in SAS 9.13 to adjust for selection, non-
response, post-stratification, and module-randomization weights (11). The standard errors
and statistical tests account for the fact that some respondents completed two modules.
Missing data on selected demographic variables were imputed using sequential regression
imputation, implemented in IVEWare (17, 18). Data were most frequently missing for
income (12.2%) and then race (1.3%); data were available for 99.5% to 100% of the other
demographic variables. For descriptive statistics, we also collapsed the 11-point response
scales for the importance of various information sources, feeling informed about screening
tests, and confidence in screening decisions into five categories (0, 1–3, 4–7, 8–9, and 10)
because the data were highly skewed and these categories captured much of the underlying
variation. We used a global chi-square test to compare discussion characteristics across the 4
modules (we reported colorectal cancer screening results separately for each gender).
Results
Overall, 2213 participants (924 men, 1289 women) aged 50 and older had discussed or
undergone any cancer screening within the previous two years (Figure 1). We randomly
selected 1308 to complete 1572 cancer-screening decision modules. In this paper, we
evaluated the 1271 modules (completed by 1082 participants) where participants reported
discussing screening before taking an action--either to undergo screening or not undergo
screening (shaded boxes in Figure 1). Those discussing screening included 198 (66.7%) of
the men selected for the prostate module, 258 (86.0%) of the men selected for the colorectal
module, 355 (89.0%) of the women selected for the colorectal module, and 460 (79.9%) of
the women selected for the breast module. Sixty-seven men completed both the prostate and
colorectal cancer screening modules, while 122 women completed both the breast and
colorectal cancer screening modules.
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Table 1 shows sociodemographic and clinical characteristics of the participants. The
majority of participants were white, with at least a high-school education, and nearly all had
health care insurance and a regular health care provider. Women had lower socioeconomic
status based on education and income and were less likely to be married. About half of the
participants reported their health as being excellent or very good. Most (80–90%) considered
themselves to be at low or average risk for cancer, but more participants considered
themselves to be at high risk for prostate or breast cancer than for colorectal cancer.
Sources of information
Health care providers were most often cited as being an extremely important information
source in the survey (Table 2). Women were more likely than men to report that health care
providers were an extremely important (= 10) source of cancer screening information for
colorectal cancer. Although media and family/friends were less often reported as extremely
important sources of information compared to providers, women were also more likely than
men to rate these sources highly. The majority of participants did not access the Internet for
cancer screening information, with the lowest use (10.2%) among those aged 70 and older
compared to 22.3% in those aged 60 to 69, and 24.9% in those aged 50 to 59(P = 0.001).
Knowledge
Women were more likely than men to report feeling highly informed about cancer
screening, though less than half of the participants in any of the modules were able to
correctly answer either the incidence or mortality knowledge questions (Table 2).
Participants were more likely to correctly answer both questions for colorectal cancer than
for prostate and breast cancer. Among men, only 3.9% were able to correctly answer both
the incidence and mortality knowledge questions for prostate cancer, a significantly lower
proportion than the 31.1% who correctly answered both questions for colorectal cancer (P <
0.001). Only 6.8% of women correctly answered both risk questions for breast cancer, while
22.7% of women correctly answered both risk questions for colorectal cancer (P < 0.001).
Most of the participants markedly overestimated the risks for cancer incidence and
mortality. Figure 2 shows the cancer incidence and mortality risks estimated by the
Surveillance, Epidemiology, and End Results program (19) and the comparable risks
estimated by our participants. The proportions of men who overestimated the risk for being
diagnosed with cancer by at least threefold were relatively high for both prostate cancer
(29.5%) and colorectal cancer (54.7%). Men similarly overestimated mortality risks for
prostate cancer (66.3%) and colorectal cancer (54.2%). The proportions of women who
overestimated the risk for being diagnosed with cancer by at least threefold were also high
for breast cancer (44.1%) and colorectal cancer (64.7%). Women similarly overestimated
the risk for dying from breast cancer (68.1%) and colorectal cancer (65.8%).
A higher perceived risk of cancer was associated with higher estimates for cancer incidence
and mortality; associations were significant for prostate and colorectal cancer though not for
breast cancer (data not shown). However, even respondents who perceived themselves to be
at low risk consistently and markedly overestimated the risks for cancer incidence (ranging
from two- to four-fold overestimates) and mortality (ranging from five- to ten-fold
overestimates).
Participants knew that screening reduced mortality for breast cancer (89.0%) and colorectal
cancer (95.8% of men, 92.2% of women). However, only 16.6% of men were able to
correctly estimate the predictive value of an abnormal PSA test as being within 21% to 40%
and only 23.6% of women were able to correctly estimate the predictive value of an
abnormal mammogram as being between 1% to 14%. Substantial proportions of participants
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overestimated predictive values for PSA (35.8%) and mammography (30.1%). Additionally,
most participants (87.7% men, 78.7% women) did not know that a screening colonoscopy
should be repeated 10 years following a normal examination. Overall, half or less of
participants were able to correctly answer even one question for any given module.
Decision processes and communication
Participants’ perspectives on the characteristics of the various screening discussions are
shown in Table 3. They usually reported that providers presented the screening test as part
of a plan to get screened regularly, though least frequently for colorectal cancer screening in
women. While providers were usually reported to have raised the idea of screening for all
four groups, men were more likely to report raising the idea of screening for prostate cancer.
Although an infrequent event, men facing prostate cancer screening decisions were more
likely to report seeking second opinions about screening. With the exception of prostate
cancer screening, the majority of participants reported that health care providers did not ask
their preferences for screening. Over half of the participants in each module felt that
decisions were shared and very few reported that the health care provider alone was the final
decision maker.
Nearly all participants reported discussing the pros of screening with a health care provider,
and the pros of screening were most likely to be discussed “a lot” for breast cancer (49.9%).
The proportion of participants who reported discussing the cons of screening to any extent
was consistently low, ranging from just 19.5% (breast cancer screening) to 29.6% (prostate
cancer screening). Nonetheless, a high proportion of participants in each module felt that the
reasons for screening were well explained--84.4% for prostate cancer, 87.2% for colorectal
cancer (men), 93.8% for colorectal cancer (women), and 88.6% for breast cancer.
Most health care providers reportedly offered an opinion about cancer screening with very
few recommending against it. The proportions of participants who reported receiving a
recommendation for screening ranged from 72.9% (prostate cancer) to 90.2% (colorectal
cancer for men).
Screening decisions
Most participants underwent cancer screening following discussions, though least often
among women facing colorectal cancer screening decisions (Table 3). Women facing breast
cancer screening decisions were most likely to report undergoing screening; they also had
the highest level of confidence in their screening decision. Most participants felt that their
amount of involvement in the screening decision was appropriate, though 11.9% of women
would have preferred more involvement in colorectal cancer screening and 16.4% of men
would have preferred more involvement in prostate cancer screening decisions.
Discussion
Our study demonstrated the challenges of achieving informed decision-making for cancer
screening decisions. Even though all participants reported discussing screening and most
described themselves as being informed about screening tests, half or less of the participants
in each module were able to correctly answer even one knowledge question. Respondents
rated providers as their most important information source, and reported that providers most
often initiated screening discussions and generally recommended screening. However,
participants reported that providers did not routinely elicit screening preferences and
screening discussions were much more likely to address the pros of screening compared to
the cons of screening.
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The consistently poor performance on knowledge questions about cancer incidence and
mortality across all cancer types was disconcerting. Knowledge of the clinical issue is
considered an essential element for informed decision-making (3). Although most
participants considered themselves informed about screening, the proportions that correctly
answered both incidence and mortality questions ranged from only 2.9% (breast cancer) to
20.7% (colorectal cancer, men) among those who considered themselves extremely well
informed (= 10). Although most respondents considered themselves to be at average or low
risk for cancer, they consistently and markedly overestimated the risks for cancer incidence
and mortality across all levels of perceived risk. They also overestimated the predictive
value of PSA tests and mammography for detecting cancer. One possible explanation for
these findings is that cancer has been widely publicized in the popular media and the
messages often do not accurately reflect the burden of disease and the relatively limited
benefits of screening (20–23). Most messages uncritically support screening, often failing to
address absolute risks, potential harms, alternatives, uncertainty, and evidence-based
screening guidelines. A consequence of these messages, as shown in a national survey of
adults without a history of cancer by Schwartz and colleagues (24), was that most (87%)
adults believed that routine cancer screening is almost always a good thing and 74%
believed that finding cancer early saves lives most or all of the time.
Health care providers can play an important role in conveying accurate information about
cancer screening to patients. Our participants reported that the process for discussing cancer
screening usually began with the provider raising the issue. Participants consistently rated
provider information as being far more important than information from other sources such
as family and friends or the media. However, the exaggerated perceptions of cancer risk
suggest that the media messages are perhaps more powerful than participants acknowledge.
Part of the problem may be that providers are not sufficiently countering the media
messages by providing patients with comprehensive and objective information about
screening.
Even though many experts emphasize that providers should be discussing the benefits and
risks of cancer screening (2, 25), patient surveys and interviews of both patients and
providers agree that patients often do not receive enough information to support screening
decisions (6–9, 26–28). The DECISIONS results confirmed the limitations in cancer
screening decisions, but went beyond the existing literature by comprehensively
characterizing the decision-making process across multiple screening decisions.
Although most participants felt that screening had been well explained by the provider, they
reported that discussions for each of the cancers consistently addressed the pros of screening
more than the cons. While the pros of screening were discussed “a lot” most frequently for
breast cancer, nearly all discussions addressed the pros to some degree. However, the
subjects reported that 70% to 80% of discussions failed to address the cons of screening at
all. This may reflect a biased recall of the discussions, particularly given the general
enthusiasm for cancer screening (24), with respondents less likely to retain negative
information. Nonetheless, in describing the screening discussions, participants also reported
that health care providers frequently had opinions about screening, with the majority
favoring screening so that a biased presentation is certainly plausible. Provider
recommendations are recognized as powerful factors for undergoing screening (29–31), but
when presented without discussing the pros and cons they undermine the goal of achieving
informed decision-making (3).
The majority of participants reported being satisfied with their level of involvement in the
decision. Indeed, studies have shown that patients value being involved in the decision-
making process for cancer screening (4, 32). However, most discussions reported by our
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participants did not clearly meet criteria for being informed because providers did not
routinely elicit screening preferences, particularly for colorectal cancer. Braddock et al have
shown that patients are often not made aware of their opportunity to participate in decision
making, emphasizing that this process should include patients exploring their preferences
(3).
A striking finding in our survey was the relatively low reported uptake of colorectal cancer
screening after a discussion. Only about 70% of women and 79% of men who reported
having a discussion underwent colorectal cancer screening compared to 86% for prostate
cancer screening and 90% for breast cancer screening. A previous analysis of men aged 40
and older who completed the prostate cancer screening module found that a provider
recommendation for screening was the most important discussion factor associated with
undergoing testing (12). In the current analyses, we observed lower uptake for colorectal
cancer screening even though most women and men did receive provider recommendations
for screening, valued provider information, and felt well informed.
Additionally, only about 63% of participants indicated that they were extremely confident in
their colorectal cancer screening decision; this was significantly lower than reported by
women completing the breast cancer module (85%), suggesting some ambivalence.
Embarrassment and anxiety about the screening tests may be a barrier for even informed
patients (33). Lafata et al identified other issues in a survey of primary care patients where
only 61% of those who discussed screening actually underwent testing (7). Discussing lower
endoscopy and instructing patients on how to make appointments and get test results were
associated with a greater likelihood of screening. However, patients who were offered a
choice among multiple screening test options or who wanted additional information were
less likely to be screened. This suggests that incomplete information may hinder informed
decision-making.
One possible solution for improving the decision-making process is to offer patients
decision aids. These aids are defined as interventions, which can be written, oral, video, or
web-based, that are designed to help patients make decisions by providing information on
the disease, presenting alternative strategies, describing the possible beneficial and harmful
outcomes, and helping patients clarify their values (2, 34). Given that screening discussions
often are incomplete or omitted, using a decision aid would allow providers to be able to
consistently present comprehensive, objective information. Decision aids have been shown
to increase shared decision-making, improve knowledge, and improve concordance between
patients’ values and their decisions (35). Prostate cancer decision aids have also been
associated with decreased interest in screening (36), while other cancer-specific decision
aids have increased uptake of breast (37) and colorectal cancer screening (38, 39). Because
providers are highly rated as important sources for cancer screening information, having
them provide decision aids could be an acceptable and powerful antidote to misleading
media messages and receiving incomplete information.
The survey had some important potential limitations. Participants were asked to recall
discussions that could have occurred up to 2 years before completing the survey module.
This step could have led to recall bias because we did not attempt to validate the responses.
However, the screening rates were similar to other national surveys, including the National
Health Interview Survey (40) and Health Information National Trends Survey (30, 41),
where participants were asked about screening or discussions that had occurred within the
previous year. Additionally, the participants were highly selected because most had access
to health care, and all had telephones and spoke English. We also required that a module
participant had either undergone or discussed cancer screening within the past 2 years. Study
results may not be generalizable to lower income, minority, or less health-conscious
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populations. We also were unable to determine whether respondents who reported testing
within the past 2 years had ever been previously tested. A screening discussion might be
structured differently for patients with previous testing, with less effort to ensure informed
decision-making. However, given changing guidelines and new research findings, providers
should not assume that screening preferences would necessarily remain constant. While we
assessed cancer knowledge in association with informed decision-making, we were not able
to determine whether the health care provider actually provided any cancer information.
Furthermore, the knowledge questions, though based on validated measures, addressed only
a limited spectrum of cancer screening knowledge. We did not ask subjects about the
potential downstream consequences of screening, including false positive tests and
undergoing biopsy, overdiagnosis, and complications from overtreatment, that are also
considered important for making informed decisions for cancer screening. Finally, we are
not able to know what kind of information is most important for decision making from a
patient’s perspective. However, the poor performance on the knowledge questions suggests
that patients may not be able to accurately determine whether they are well informed.
Patients should have some key objective knowledge, though determining what constitutes
essential knowledge remains a challenge.
Cancer screening discussions across all screening tests apparently did not routinely meet
criteria for informed decision-making. Participants reported that health care providers
frequently failed to discuss the cons of screening and did not routinely elicit patient
preferences. Although participants reported feeling well informed, they performed poorly in
answering knowledge questions, and significantly overestimated incidence and mortality
risks and the predictive values of PSA tests and mammography. Participants highly valued
health care provider information and recommendations, suggesting that providers can have a
vital role in ensuring that informed decision-making occurs for cancer screening decisions.
Further research should address strategies, such as provider training, decision aids, or
coaching interventions, to facilitate this process.
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Cohort assembly. Shaded boxes indicate subjects included in this manuscript.
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